| Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients O Benveniste, P Chérin, T Maisonobe, R Merat, O Chosidow, L Mouthon, ... The Journal of Immunology 167 (6), 3521-3529, 2001 | 113 | 2001 |
| Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus J Richardson, G Pancino, R Merat, T Leste-Lasserre, A Moraillon, ... Journal of virology 73 (5), 3661-3671, 1999 | 90 | 1999 |
| HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi’s sarcoma-associated herpesvirus (KSHV) reactivation R Merat, A Amara, C Lebbe, H de The, P Morel, A Saib International journal of cancer 97 (6), 791-795, 2002 | 67 | 2002 |
| Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1 R Merat, H Raoul, T Leste-Lasserre, P Sonigo, G Pancino Journal of virology 73 (7), 5698-5706, 1999 | 39 | 1999 |
| Psammomatous melanotic schwannoma: a challenging histological diagnosis R Merat, I Szalay-Quinodoz, E Laffitte, G Kaya Dermatopathology 2 (3), 67-70, 2015 | 15 | 2015 |
| Head and neck porocarcinoma: SEER analysis of epidemiology and survival M Scampa, R Merat, DF Kalbermatten, CM Oranges Journal of Clinical Medicine 11 (8), 2185, 2022 | 12 | 2022 |
| Recognition of early melanoma: a monocentric dermoscopy follow‐up study comparing de novo melanoma with nevus‐associated melanoma D Alvarez Martinez, WH Boehncke, G Kaya, R Merat International journal of dermatology 57 (6), 692-702, 2018 | 12 | 2018 |
| Evaluation of the National Swiss skin cancer screening campaign 2013: do we do the right thing RP Braun, K Ulrich, R Hunger, O Gaide, A Arnold, R Merat, R Dummer, ... Dermatology 233 (5), 404-409, 2018 | 11 | 2018 |
| Swiss recommendations for cutaneous basal cell carcinoma E Ramelyte, MC Nägeli, R Hunger, R Merat, O Gaide, AA Navarini, ... Dermatology 239 (1), 122-131, 2023 | 9 | 2023 |
| Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018 M Scampa, R Merat, E Tzika, DF Kalbermatten, CM Oranges JAAD international 7, 13-21, 2022 | 9 | 2022 |
| Anti-PD-1-induced hidradenitis suppurativa A Maillard, D Pastor, R Merat Dermatopathology 8 (1), 37-39, 2021 | 9 | 2021 |
| Skin cancer screening in Switzerland: Cross-sectional trends (1997–2012) in socioeconomic inequalities S Dumont, S Cullati, O Manor, DS Courvoisier, C Bouchardy, R Merat, ... Preventive medicine 129, 105829, 2019 | 8 | 2019 |
| Overexpression of the human antigen R suppresses the immediate paradoxical proliferation of melanoma cell subpopulations in response to suboptimal BRAF inhibition M Fernandez, H Sutterlüty‐Fall, C Schwärzler, S Lemeille, WH Boehncke, ... Cancer medicine 6 (7), 1652-1664, 2017 | 8 | 2017 |
| Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma R Merat, A Bugi-Marteyn, LJ Wrobel, C Py, Y Daali, C Schwärzler, ... Biochemical and biophysical research communications 517 (2), 181-187, 2019 | 7 | 2019 |
| Pseudoerysipelas resulting from acute anterior tibial compartment syndrome A Petit, M Sigal, R Merat, E Pepin, JC Couffinhal Journal of the American Academy of Dermatology 34 (3), 521-522, 1996 | 6 | 1996 |
| A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma A Bugi-Marteyn, F Noulet, N Liaudet, R Merat Neoplasia 23 (8), 775-782, 2021 | 3 | 2021 |
| Hu antigen R (HuR) heterogeneous expression quantification as a prognostic marker of melanoma N Liaudet, M Fernandez, L Fontao, G Kaya, R Merat Journal of cutaneous pathology 45 (5), 333-336, 2018 | 3 | 2018 |
| In vivo reflectance confocal microscopy: a useful non-invasive tool to assess the response to isolated limb perfusion for superficial pigmented melanoma in-transit metastatic … R Merat, WH Boehncke, G Kaya Dermatology practical & conceptual, 2017 | 2 | 2017 |
| Multiple palpebral syringomas occurring after initiation of BRAF inhibition therapy in a patient with metastatic melanoma R Merat, O Seyde, E Fernandez, G Kaya JAAD case reports 2 (6), 482-484, 2016 | 2 | 2016 |
| Post-transcriptional control of melanocyte differentiation markers. 65th meeting of the Society for investigative dermatology R Merat, (corresponding author), H Sutterluty, J Burch, RD Streilein, ... Journal of Investigative Dermatology 122 (3), A157-A157 937, 2004 | 2 | 2004 |
